...
首页> 外文期刊>Saudi Pharmaceutical Journal >Quinoline based furanones and their nitrogen analogues: Docking, synthesis and biological evaluation
【24h】

Quinoline based furanones and their nitrogen analogues: Docking, synthesis and biological evaluation

机译:基于喹啉的呋喃酮及其氮类似物:对接,合成和生物学评估

获取原文

摘要

A small library of twenty-four quinoline based butenolides also known as furanones and their nitrogen analogues was prepared by using two different aroylpropionic acids, viz. 3-(2-naphthoyl)propionic acid (3) and 3-(biphenyl-4-yl)propionic acid (4), as starting materials. The 3-aroylpropionic acids were reacted with different 6-substituted-2-chloroquinolin-3-carbaldehydes (2a-d) to obtain the corresponding furan-2(3H)-ones (5a-h). The purified and characterized furanones were then converted into their corresponding 2(3H)-pyrrolones (6a-h) and N-benzyl-pyrrol-2(3H)-ones (7a-h). The antimicrobial activities of the title compounds were evaluated against two strains of each Gram +ve (Staphylococcus aureus and Bacillus subtilis), Gram -ve bacteria (Escherichia coli and Pseudomonas aeruginosa) and against fungal strains of Aspergillus niger and Aspergillus flavus. In vivo anti-inflammatory potential of the title compounds was investigated by standard method. Majority of the compounds showed significant antibacterial activity against both the Gram +ve strains. Eight most potent anti-inflammatory compounds (5b, 5d, 5h, 6b, 7b, 7d, 7f, 7h) which exhibited 53% inhibition in edema, were also screened for their in vivo analgesic activity. All the tested compounds were found to have significant reduction in ulcerogenic action but only three compounds (5d, 5h and 7h) showed comparable analgesic activity to standard drug, diclofenac. The results were also validated using in silico approach and maximum mol doc score was obtained for compounds 7a-h. On comparing the in vivo and in silico anti-inflammatory results of synthesized compounds, N-benzyl pyrrolones (7a-h) emerged as the potent anti-inflammatory agents. It was also observed that compounds that possess electron withdrawing group such as ?Cl or NO"2 are more biologically active.
机译:通过使用两种不同的芳酰基丙酸制备一个小库,该库由24个基于喹啉的丁烯内酯(也称为呋喃酮)及其氮类似物组成。以3-(2-萘甲酰基)丙酸(3)和3-(联苯-4-基)丙酸(4)为原料。使3-芳酰基丙酸与不同的6-取代的-2-氯喹啉-3-甲醛(2a-d)反应以获得相应的呋喃-2(3H)-one(5a-h)。然后将纯化和表征的呋喃酮转化为其相应的2(3H)-吡咯烷酮(6a-h)和N-苄基-吡​​咯-2(3H)-酮(7a-h)。评价了标题化合物对两种菌株的抗微生物活性,每种菌株分别对革兰氏+ ve(金黄色葡萄球菌和枯草芽孢杆菌),革兰氏细菌(大肠杆菌和铜绿假单胞菌)的两种菌株以及对黑曲霉和黄曲霉的真菌菌株。通过标准方法研究了标题化合物的体内抗炎潜力。多数化合物对革兰氏+ ve菌株均表现出显着的抗菌活性。还筛选了八种最有效的消炎化合物(5b,5d,5h,6b,7b,7d,7f,7h),它们对水肿的抑制作用大于53%,并具有体内镇痛活性。发现所有测试化合物的致溃疡作用均明显降低,但只有三种化合物(5d,5h和7h)显示出与标准药物双氯芬酸相当的镇痛活性。还使用计算机方法验证了结果,并获得了化合物7a-h的最大mol doc分数。在比较合成化合物的体内和计算机模拟消炎结果时,出现了N-苄基吡咯烷酮(7a-h)作为有效的消炎剂。还观察到具有吸电子基团的化合物,如αCl或NO 2,具有更高的生物活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号